Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 13, 2023

SELL
$7.85 - $8.94 $785 - $894
-100 Reduced 0.88%
11,204 $93,000
Q2 2023

Jul 11, 2023

SELL
$8.04 - $9.0 $13,563 - $15,183
-1,687 Reduced 12.99%
11,304 $94,000
Q1 2023

Apr 07, 2023

BUY
$7.57 - $8.37 $734 - $811
97 Added 0.75%
12,991 $105,000
Q4 2022

Jan 25, 2023

SELL
$5.96 - $8.06 $214 - $290
-36 Reduced 0.28%
12,894 $0
Q3 2022

Oct 24, 2022

BUY
$5.63 - $7.5 $72,795 - $96,975
12,930 New
12,930 $79,000

Others Institutions Holding HLN

About Haleon plc


  • Ticker HLN
  • Exchange
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 4,617,290,240
  • Market Cap $44.8B
  • Description
  • Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, mineral...
More about HLN
Track This Portfolio

Track Thrive Wealth Management, LLC Portfolio

Follow Thrive Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Thrive Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Thrive Wealth Management, LLC with notifications on news.